The Statistical Fragility of Platelet-Rich Plasma as Treatment for Chronic Noninsertional Achilles Tendinopathy: A Systematic Review and Meta-analysis.

Achilles tendinopathy Fragility Index Fragility Quotient orthobiologics platelet-rich plasma randomized controlled trials statistical fragility

Journal

Foot & ankle orthopaedics
ISSN: 2473-0114
Titre abrégé: Foot Ankle Orthop
Pays: United States
ID NLM: 101752333

Informations de publication

Date de publication:
Jul 2022
Historique:
entrez: 2 9 2022
pubmed: 3 9 2022
medline: 3 9 2022
Statut: epublish

Résumé

Randomized controlled trial (RCT) outcomes reaching statistical significance, frequently determined by The present study was a systematic review and meta-analysis of RCTs comparing outcomes after PRP injection vs alternative treatment in patients with AT. Representative data sets were generated for each reported continuous outcome event using summary statistics. Fragility indices refer to the minimal number of patients whose status would have to change from a nonevent to an event to turn a statistically significant result into a nonsignificant result, or vice versa. The fragility index (FI) and continuous FI (CFI) were determined for dichotomous and continuous outcomes, respectively, by manipulating each data set until reversal of significance (a=0.05) was achieved. The corresponding fragility quotient (FQ) and continuous FQ (CFQ) were calculated by dividing FI/CFI by sample size. Of 432 studies screened, 8 studies (52 outcome events) were included in this analysis. The 12 dichotomous outcomes had a median FI of 4.5 (FQ: 0.111), and the 40 continuous outcomes had a median CFI of 5 (CFQ: 0.154). All 52 outcome events included lost-to-follow-up data, and 12 (23.1%) indicated a greater number of patients lost to follow-up than the FI or CFI. Our findings suggest that RCTs evaluating PRP for AT therapy lack statistical robustness, because changing only a small number of events may alter outcome significance. Level II, therapeutic study.

Sections du résumé

Background UNASSIGNED
Randomized controlled trial (RCT) outcomes reaching statistical significance, frequently determined by
Methods UNASSIGNED
The present study was a systematic review and meta-analysis of RCTs comparing outcomes after PRP injection vs alternative treatment in patients with AT. Representative data sets were generated for each reported continuous outcome event using summary statistics. Fragility indices refer to the minimal number of patients whose status would have to change from a nonevent to an event to turn a statistically significant result into a nonsignificant result, or vice versa. The fragility index (FI) and continuous FI (CFI) were determined for dichotomous and continuous outcomes, respectively, by manipulating each data set until reversal of significance (a=0.05) was achieved. The corresponding fragility quotient (FQ) and continuous FQ (CFQ) were calculated by dividing FI/CFI by sample size.
Results UNASSIGNED
Of 432 studies screened, 8 studies (52 outcome events) were included in this analysis. The 12 dichotomous outcomes had a median FI of 4.5 (FQ: 0.111), and the 40 continuous outcomes had a median CFI of 5 (CFQ: 0.154). All 52 outcome events included lost-to-follow-up data, and 12 (23.1%) indicated a greater number of patients lost to follow-up than the FI or CFI.
Conclusion UNASSIGNED
Our findings suggest that RCTs evaluating PRP for AT therapy lack statistical robustness, because changing only a small number of events may alter outcome significance.
Level of Evidence UNASSIGNED
Level II, therapeutic study.

Identifiants

pubmed: 36051864
doi: 10.1177/24730114221119758
pii: 10.1177_24730114221119758
pmc: PMC9424894
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24730114221119758

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. ICMJE forms for all authors are available online.

Références

J Hand Surg Am. 2019 Aug;44(8):698.e1-698.e7
pubmed: 30420197
Spine J. 2015 Oct 1;15(10):2188-97
pubmed: 26072464
Br J Sports Med. 2018 Dec;52(24):1564-1574
pubmed: 30170996
J Sport Health Sci. 2020 Jun 30;:
pubmed: 32619656
J Clin Epidemiol. 2014 Jun;67(6):622-8
pubmed: 24508144
Am J Sports Med. 2016 Aug;44(8):1931-40
pubmed: 27400714
Acta Orthop. 2017 Aug;88(4):416-421
pubmed: 28296518
Medicine (Baltimore). 2019 Apr;98(16):e15278
pubmed: 31008973
Bone Joint Res. 2017 Apr;6(4):231-244
pubmed: 28450316
JAMA Surg. 2019 Jan 01;154(1):74-79
pubmed: 30422256
JAMA. 2021 Jul 13;326(2):137-144
pubmed: 34255009
Arthroscopy. 2021 Jun;37(6):1983-1989
pubmed: 33539980
Nat Hum Behav. 2018 Jan;2(1):6-10
pubmed: 30980045
JAMA. 2010 Jan 13;303(2):144-9
pubmed: 20068208
Am J Sports Med. 2021 Oct;49(12):3437-3442
pubmed: 33646884
Clin Podiatr Med Surg. 2017 Apr;34(2):195-205
pubmed: 28257674
J Am Acad Orthop Surg Glob Res Rev. 2020 Jun 01;4(6):
pubmed: 32656478
J Gen Intern Med. 2022 Jan;37(1):206-211
pubmed: 34357573
Bone Joint Res. 2013 Oct 17;2(10):227-32
pubmed: 24135556
J Clin Epidemiol. 2021 Aug;136:20-25
pubmed: 33684509
J Pediatr Orthop. 2018 Sep;38(8):e418-e423
pubmed: 29979332
Clin J Sport Med. 2005 May;15(3):133-5
pubmed: 15867554
Scand J Med Sci Sports. 2013 Dec;23(6):669-86
pubmed: 22846101
Cochrane Database Syst Rev. 2015 May 26;(5):CD010960
pubmed: 26009861
J Am Acad Orthop Surg Glob Res Rev. 2021 Sep 2;5(9):
pubmed: 34491976
JAMA. 2005 Jul 13;294(2):218-28
pubmed: 16014596
Connect Tissue Res. 2006;47(4):200-6
pubmed: 16987751
Knee Surg Sports Traumatol Arthrosc. 2018 Jul;26(7):2000-2010
pubmed: 28251260
Am J Sports Med. 2017 Jul;45(9):2164-2170
pubmed: 27895038
PM R. 2021 Dec;13(12):1340-1349
pubmed: 33644963
J Am Acad Orthop Surg. 2019 Jan 15;27(2):e50-e63
pubmed: 30300216
Clin Orthop Relat Res. 2018 Aug;476(8):1633-1641
pubmed: 29601383
Am J Sports Med. 2011 Aug;39(8):1623-9
pubmed: 21602565
BMJ Open. 2013 Feb 07;3(2):
pubmed: 23396504
Foot Ankle Int. 2020 Jun;41(6):744-754
pubmed: 32349544
JAMA. 2018 Apr 10;319(14):1429-1430
pubmed: 29566133
J Clin Epidemiol. 1990;43(2):201-9
pubmed: 2303850
Trials. 2014 Oct 16;15:399
pubmed: 25322807
Sports Med. 2012 Oct 1;42(10):891-905
pubmed: 22827721
Crit Care Med. 2016 Nov;44(11):e1142-e1143
pubmed: 27755081
J Am Acad Orthop Surg Glob Res Rev. 2021 Nov 19;5(11):
pubmed: 34807889
Am J Sports Med. 2017 Jul;45(9):2034-2043
pubmed: 28530451
Cochrane Database Syst Rev. 2010 Jan 20;(1):MR000013
pubmed: 20091668

Auteurs

Amy L Xu (AL)

Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Carlos Ortiz-Babilonia (C)

Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Orthopaedic Surgery, University of Puerto Rico Medical Sciences Campus, San Juan, PR.

Arjun Gupta (A)

Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Orthopaedic Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.

Davis Rogers (D)

Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Amiethab A Aiyer (AA)

Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Ettore Vulcano (E)

Department of Orthopaedic Surgery, Columbia University Mount Sinai Medical Center, Miami, FL, USA.

Classifications MeSH